Bharat Biotech reiterates its assurance on safety of Covaxin
As per company, the vaccine hasn't reported any incidents of blood clots, Thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc.
As per company, the vaccine hasn't reported any incidents of blood clots, Thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc.